FDA Drug Recalls

Recalls / Class II

Class IID-0471-2022

Product

Cystex Urinary Pan Relief (NSAID) (methenamine 162mg, sodium salicylate 162.5mg tablets) packaged in a) 40-count blisters and b) 20-count blisters, Distributed by: Clarion Brands, LLC 27070 Miles Road, Suite A Solon, OH 44139, NDC 69693-512-40

Brand name
Cystex
Generic name
Methenamine, Sodium Salicylate
Active ingredients
Methenamine, Sodium Salicylate
Route
Oral
NDC
69693-512
Affected lot / code info
Lot #: a) 19A043, 19A093, Exp. Date 01/2022; 19B062,19C079,19C080, Exp. Date 03/2022; 19D041, Exp. Date 04/2022; 19E035, 19E087, Exp. Date 05/2022; 19G084, Exp. Date 08/2022; 19H098, Exp. Date 09/2022 b) 19H098A, Exp. Date 09/2022

Why it was recalled

cGMP deviations

Recalling firm

Firm
Ultra Seal Corporation
Manufacturer
Clarion Brands, LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
521 Main St, N/A, New Paltz, New York 12561-1609

Distribution

Quantity
a) 702,240 blisters, b) 30,180 blisters
Distribution pattern
Nationwide within the United States

Timeline

Recall initiated
2022-01-24
FDA classified
2022-01-31
Posted by FDA
2022-02-09
Terminated
2023-10-16
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0471-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.